AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. EBITDA margin (%)

KYORIN Pharmaceutical Co., Ltd.【JP:4569】

Market cap
¥111.4B
P/E ratio
20.7x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Mar 31, 202513.2+53.13%
Mar 31, 20248.6+8.93%
Mar 31, 20237.9-4.24%
Mar 31, 20228.3-9.05%
Mar 31, 20219.1-6.81%
Mar 31, 20209.8-7.00%
Mar 31, 201910.5-6.95%
Mar 31, 201811.3-7.36%
Mar 31, 201712.2-37.81%
Mar 31, 201619.6+24.35%
Mar 31, 201515.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)